Graf Akcie BSX (Boston Scientific Corp.). Diskuze k akciím BSX. Aktuální informace BSX.

Základní informace o společnosti Boston Scientific Corp. (Akcie BSX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 61.98B
Hodnota podniku (EV) 68.17B
Tržby 11.197B
EBITDA 2.114B
Zisk 526M
Růst v tržbách Q/Q 53.62 %
Růst v tržbách Y/Y 10.24 %
P/E (Cena vůči ziskům) 116.65
Forward P/E 0.01
EV/Sales 6.09
EV/EBITDA 32.25
EV/EBIT 75.50
PEG 1.61
Price/Sales 5.54
P/FCF 31.72
Price/Book 4.04
Účetní hodnota na akcii 10.67
Hotovost na akcii 1.21
FCF vůči ceně 3.15 %
Počet zaměstnanců 2,020
Tržba na zaměstnance 5543000
Profit margin -0.83 %
Operating margin 4.19 %
Gross margin 65.05 %
EBIT margin 8.06 %
EBITDA margin 18.88 %
EPS - Zisk na akcii 0.37
EPS - Kvartální růst 400.00 %
EPS - Očekávaný růst příští rok 8.11 %
Return on assets 1.88 %
Return on equity 3.72 %
ROIC 0.92 %
ROCE 3.33 %
Dluhy/Equity 1.01
Čistý dluh/EBITDA 13.36
Current ratio 1.66
Quick Ratio 1.31
Volatilita 2.25
Beta 0.95
RSI 44.22
Cílová cena analytiků 43
Známka akcie (dle analytiků) 1.32
Insider ownership 0.25 %
Institutional ownership 93.96 %
Počet akcií 1.424B
Procento shortovaných akcií 0.80 %
Short ratio 1.51 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1992
Země United States

Finanční výsledky akcie BSX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$9,913$10,735$9,823$9,048$8,386$7,477
Cost Of Goods Sold$3,465$3,116$2,813$2,593$2,424$2,173
Gross Profit$6,448$7,619$7,010$6,455$5,962$5,304
Research And Development Expenses$1,143$1,174$1,113$997$920$876
SG&A Expenses$3,832$4,006$3,639$3,362$3,178$2,943
Other Operating Income Or Expenses$-638$-185$-117$-209$-844$-1,247
Operating Expenses$9,992$9,218$8,317$7,763$7,939$7,760
Operating Income$-79$1,517$1,506$1,285$447$-283
Total Non-Operating Income/Expense$1$-831$-85$-353$-270$-367
Pre-Tax Income$-79$687$1,422$933$177$-650
Income Taxes$2$-4,013$-249$828$-170$-411
Income After Taxes$-81$4,700$1,671$105$347$-239
Other Income------
Income From Continuous Operations$-81$4,700$1,671$105$347$-239
Income From Discontinued Operations------
Net Income$-115$4,700$1,671$104$347$-239
EBITDA$1,577$2,633$2,435$2,133$1,273$505
EBIT$-79$1,517$1,506$1,285$447$-283
Basic Shares Outstanding1,4171,3921,3811,3701,3581,341
Shares Outstanding1,4171,4111,4011,3931,3771,341
Basic EPS$-0.08$3.38$1.21$0.08$0.26$-0.18
EPS - Earnings Per Share$-0.08$3.33$1.19$0.08$0.25$-0.18
# 2020 2019 2018 2017 2016 2015
Current Ratio1.81850.96570.7610.6760.9031.4284
Long-term Debt / Capital0.37330.38240.3550.35240.4460.4731
Debt/Equity Ratio0.59660.72120.80860.80090.81450.8983
Gross Margin65.045970.982871.373371.341771.094770.9376
Operating Margin-0.796914.131415.331414.2025.3303-3.7849
EBIT Margin-0.796914.131415.331414.2025.3303-3.7849
EBITDA Margin15.908424.527324.788823.574315.18016.754
Pre-Tax Profit Margin-0.79696.399614.476210.31172.1107-8.6933
Net Profit Margin-1.160143.78217.01111.14944.1378-3.1965
Asset Turnover0.32210.35120.46780.47520.46340.4123
Inventory Turnover Ratio2.56481.97342.41252.40542.53822.1388
Receiveable Turnover6.47495.87256.10885.8455.6975.8643
Days Sales In Receivables56.371962.153759.749662.44764.068762.2409
ROE - Return On Equity-0.528533.86919.15191.49765.1537-3.7816
Return On Tangible Equity14.9447-112.3059-30.0702-1.8032-5.9543.7656
ROA - Return On Assets-0.263215.37717.95750.55141.9176-1.318
ROI - Return On Investment-0.331220.917712.35130.96982.8553-1.9927
Book Value Per Share10.81879.94826.30235.10524.94314.6931
Operating Cash Flow Per Share-0.23721.0804-0.80270.16560.3431-0.443
Free Cash Flow Per Share-0.17220.974-0.78920.18860.2753-0.4317

Porovnání s konkurencí: Akcie BSX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BSX 116.65 1.61 10.24 % 8.11 % 3.72 % 4.04 -0.83 %
Akcie ANGO N/A 5.96 10.97 % -300.00 % -7.68 % 2.30 -10.84 %
Akcie CNMD 73.53 1.36 12.44 % -13.64 % 7.57 % 5.66 1.10 %
Akcie CNMD 73.53 1.36 12.44 % -13.64 % 7.57 % 5.66 1.10 %
Akcie EW 46.47 2.58 13.96 % 5.88 % 31.49 % 14.46 18.77 %
Akcie MDT 43.33 2.49 13.14 % 26.47 % 7.62 % 3.24 11.97 %
Akcie MMSI 136.71 3.48 7.10 % 4.76 % 2.93 % 4.23 -1.02 %
Akcie SYK 47.63 1.93 15.47 % 8.41 % 15.61 % 7.45 11.14 %
Akcie TFX 48.39 2.99 6.33 % 9.75 % 10.46 % 4.99 13.22 %

Nedávné obchody insiderů: Akcie BSX

Jméno Obchod Cena Objem
Joseph Michael Fitzgerald
EVP, Pres, and Interven Cardio
Option
21 Feb 2021
$38.03 $302,339
Edward F Mackey
EVP and Operations
Option
21 Feb 2021
$38.03 $213,843
Michael F Mahoney
Chairman, President, and CEO
Option
21 Feb 2021
$38.03 $1,521,162
Ian T Meredith
EVP Global Chief Med Officer
Option
21 Feb 2021
$38.03 $38,486
Jeffrey B. Mirviss
EVP, Pres, and Periph Intervent
Option
21 Feb 2021
$38.03 $194,790
Jonathan Monson
Vice President, Global Controller, and CAO
Option
21 Feb 2021
$38.03 $67,769
Maulik Nanavaty
SVP, Pres, and Neuromodulation
Option
21 Feb 2021
$38.03 $136,756
Scott Olson
SVP, Pres, and Rhythm Management
Option
21 Feb 2021
$38.03 $41,453
Desiree Ralls Morrison
SVP, GC, and Corp Secretary
Option
21 Feb 2021
$38.03 $50,352
Meghan Scanlon
SVP, Pres, and Urology Pelvic Health
Option
21 Feb 2021
$38.03 $73,702
Eric Francis Yves Thepaut
EVP, Pres, Eur, Mid-East, and Afr
Option
21 Feb 2021
$38.03 $142,270

Diskuze k akciím BSX